Tissue Factor Expression on Monocyte Subpopulations during Normal Pregnancy

Valerie A. Holmes; Julie M. W. Wallace; W. S. Gilmore; P. McFaul; H. D. Alexander

doi:10.1055/s-0037-1613117

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2002; 87(06): 953-958
DOI: 10.1055/s-0037-1613117

Review Article

Schattauer GmbH

Tissue Factor Expression on Monocyte Subpopulations during Normal Pregnancy

Valerie A. Holmes

¹Northern Ireland Centre for Diet and Health (NICHE), University of Ulster, Coleraine

³Department of Haematology, Belfast City Hospital, Belfast, UK

,

Julie M. W. Wallace

¹Northern Ireland Centre for Diet and Health (NICHE), University of Ulster, Coleraine

,

W. S. Gilmore

¹Northern Ireland Centre for Diet and Health (NICHE), University of Ulster, Coleraine

,

P. McFaul

²Department of Obstetrics and Gynaecology

,

H. D. Alexander

³Department of Haematology, Belfast City Hospital, Belfast, UK

› Institutsangaben

Abstract

Summary

Pregnancy is often referred to as a hypercoagulable state due to changes in the haemostatic system. Tissue factor (TF) is the initiator of blood clotting in vivo. The effect of pregnancy on monocyte TF expression was determined in a longitudinal case control study (89 pregnant, 39 non-pregnant). Using whole blood flow cytometry and CD14 as a monocyte marker, TF expression was measured on all CD14 positive, CD14^Bright and CD14^Dim cells. TF expression was significantly lower in pregnant women than in non-pregnant control subjects, on all CD14 positive cells at 20 and 35 weeks, on CD14^Bright cells at 12 and 35 weeks and on CD14^Dim cells at 20 weeks. Additionally, we report that a higher percentage of CD14^Dim than CD14^Bright cells express TF. These results suggest that, in order to maintain homeostasis in haemostasis in an otherwise hypercoagulable state, monocyte TF expression is reduced during normal pregnancy.

Keywords

Pregnancy - tissue factor - monocyte - flow cytometry - haemostasis

Volltext

Referenzen

References
1 McColl MD, Ramsay JE, Tait RC, Walker ID, McCall F, Conkie JA, Carty MJ, Greer IA. Risk factors for pregnancy associated venous thromboembolism. Thromb Haemost 1997; 78: 1183-8.
2 Hellgren M, Blomback M. Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. Gynecol Obstet Invest 1981; 12: 141-54.
3 Stirling Y, Woolf L, North WRS, Seghatchian MJ, Meade TW. Haemostasis in normal pregnancy. Thromb Haemost 1984; 52: 176-82.
4 Eichinger S, Weltermann A, Philipp K, Hafner E, Kaider A, Kittl E, Brenner B, Mannhalter C, Lechner K, Kyrle PA. Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden. Thromb Haemost 1999; 82: 1232-6.
5 Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Am J Pathol 1989; 134: 1087-97.
6 Giesen PLA, Nemerson Y. Tissue factor on the loose. Sem Thromb Haemost 2000; 26: 379-84.
7 Giesen PLA, Rauch U, Bohrmann B, Kling D, Roque M, Fallon JT, Badimon JJ, Himber J, Riederer MA, Nemerson Y. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci USA 1999; 96: 2311-5.
8 Nijziel MR, Oerle R, Pampus ECM, Vet HCW, Hillen HFP, Hamulyak K. Increased D-dimer levels correlate with binding of activated protein C, but not tissue factor expression, on peripheral blood monocytes in cancer patients. Am J Hematol 2000; 64: 282-6.
9 Al-Saady NM, Leatham EW, Gupta S, Kwan JTC, Eastwood JB, Seymour CA. Monocyte expression of tissue factor and adhesion molecules: the link with accelerated coronary artery disease in patients with chronic renal failure. Heart 1999; 81: 134-40.
10 Schwager I, Jungi TW. Effect of human recombinant cytokines on the induction of macrophage procoagulant activity. Blood 1994; 83: 152-60.
11 Neumann F, Ott I, Marx N, Luther T, Kenngott S, Gawaz M, Kotzsch M, Schomig A. Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity. Arterioscler Thromb Vasc Biol 1997; 17: 3399-405.
12 Shands JW. The endotoxin-induced procoagulant of mouse exudate macrophages: a factor-X activator. Blood 1983; 62: 333-40.
13 Khajuria A, Houston DS. Induction of monocyte tissue factor expression by homocysteine: a possible mechanism for thrombosis. Blood 2000; 96: 966-72.
14 Celi A, Pellegrini G, Lorenzet R, De Blasi A, Ready N, Furie BC, Furie B. P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci USA 1994; 91: 8767-71.
15 Cermak J, Key NS, Bach RR, Balla J, Jacob HS, Vercellotti GM. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993; 82: 513-20.
16 Semeraro N, Colucci M. Tissue factor in health and disease. Thromb Haemost 1997; 78: 759-64.
17 Freeburn JC, Wallace JMW, Strain JJ, Sinnamon DG, Craig BM, Johnson D, Gilmore WS. Monocyte tissue factor-like activity in post myocardial infarction patients. Br J Haematol 1998; 102: 605-8.
18 Ten Cate H, Timmerman J, Levi M. The pathophysiology of disseminated intravascular coagulation. Thromb Haemost 1999; 82: 713-7.
19 Ziegler-Heitbrock HWL, Passlick B, Flieger D. The monoclonal antimonocyte antibody My4 stains B lymphocytes and two distinct monocyte subsets in human peripheral blood. Hybridoma 1988; 07: 521-7.
20 Ziegler-Heitbrock HWL. Heterogeneity of human blood monocytes: the CD14+CD16+ subpopulation. Immunol Today 1996; 17: 424-8.
21 Fingerle G, Pforte A, Passlick B, Blumenstein M, Strobel M, Ziegler-Heitbrock HW. The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients. Blood 1993; 82: 3170-6.
22 Senno SL, Pechet L, Bick RL. Disseminated intravascular coagulopathy (DIC): pathophysiology, laboratory diagnosis, and management. J Intensive Care Med 2000; 15: 144-58.
23 Frankenberger M, Sternsdorf T, Pechumer H, Pforte A, Ziegler-Heitbrock HW. Differential cytokine expression in human blood monocyte subpopulations: a polymerase chain reaction analysis. Blood 1996; 87: 373-7.
24 Amirkhosravi A, Alexander M, May K, Francis DA, Warnes G, Biggerstaff J, Francis JL. The importance of platelets in the expression of monocyte tissue factor antigen measured by a new whole blood flow cytometric assay. Thromb Haemost 1997; 75: 87-95.
25 Gherman RB, Goodwin TM, Leung B, Byrne JD, Hethumumi R, Montoro M. Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy. Obstet Gynecol 1999; 94: 730-4.
26 Department of Health, Welsh Office, Scottish Home and Health Department and Department of Health and Social Services Northern Ireland. Confidential enquiries into maternal deaths in the United Kingdom 1994 to 1996. London: TSO; 1998
27 McColl MD, Walker ID, Greer IA. The role of inherited thrombophilia in venous thromboembolism associated with pregnancy. Br J Obstet Gynaecol 1999; 106: 756-66.
28 Jungi TW, Brcic M, Eperon S, Albrecht S. Transforming growth factor-beta and interleukin-10, but not interleukin-4, down-regulate procoagulant activity and tissue factor expression in human monocyte-derived macrophages. Thromb Res 1994; 76: 463-74.
29 Ernofsson M, Tenno T, Siegbahn A. Inhibition of tissue factor surface expression in human peripheral blood monocytes exposed to cytokines. Br J Haematol 1996; 95: 249-57.
30 Osterud B. The high responder phenomenon: enhancement of LPS induced tissue factor activity in monocytes by platelets and granulocytes. Platelets 1995; 06: 119-25.
31 Plum J, Thiery M, Sabbe L. Distribution of mononuclear cells during pregnancy. Clin Exp Immunol 1978; 31: 45-9.